sST2
Showing 1 - 25 of 418
Acute/Chronic Coronary Syndrome After Revascularization
Recruiting
- Myocardial Ischemia
- +2 more
- percutanous coronary angiography with stenting
-
Qinā, Egypt
- +1 more
Jan 6, 2023
sST2 and Troponin I-hs in Patients With Acute Chest Pain
Active, not recruiting
- Acute Chest Pain
- Acute Coronary Syndrome
- Multimarker approach in acute coronary syndrome
-
Roma, ItalySilvia Baroni
Feb 21, 2023
Heart Failure Trial in Montpellier (Biomarker guided therapy)
Recruiting
- Heart Failure
- Biomarker guided therapy
-
Montpellier, Occitanie, France
- +1 more
Dec 31, 2021
Mild Cognitive Impairment, Obstructive Sleep Apnea Trial in Hong Kong (Trazodone, Placebo)
Recruiting
- Mild Cognitive Impairment
- Obstructive Sleep Apnea
- Trazodone
- Placebo
-
Hong Kong, Hong KongThe Chinese University of Hong Kong
Jul 18, 2022
Patients Hospitalized for Acute Heart Failure According to
Completed
- Heart Failure
- Evaluation of the evolution of biological markers from the biobank.
-
Nîmes, Gard, France
- +1 more
Jul 26, 2022
High Grade Glioma, Meningioma, Embryonal Tumor Trial in United States (LUTATHERA® (Lutetium Lu 177 dotatate))
Recruiting
- High Grade Glioma
- +12 more
- LUTATHERA® (Lutetium Lu 177 dotatate)
-
Aurora, Colorado
- +8 more
Jan 16, 2023
sST2 and Cardiac Surgery
Completed
- Cardiac Surgery
-
Montpellier, FranceUhmontpellier
Mar 9, 2020
HFpEF - Heart Failure With Preserved Ejection Fraction, Colchicine Trial (Colchicine)
Not yet recruiting
- HFpEF - Heart Failure With Preserved Ejection Fraction
- Colchicine
- (no location specified)
Nov 24, 2022
PET Imaging of Giant Cell and Takayasu Arteritis
Active, not recruiting
- Giant Cell Arteritis
- Takayasu Arteritis
- PET-MRI
-
Cambridge, Cambridgeshire, United Kingdom
- +1 more
Jul 31, 2022
Soluble ST2 and Cardiovascular Outcome
Recruiting
- Cardiovascular Disease
- soluble ST2
-
Nanjing, Jiangsu, ChinaThe first affiliated hospital of nanjing medical university
Apr 15, 2022
Hypercholesterolemia, Hypercholesterolemia, Familial Trial in Cambridge (PCSK9 inhibitor, 68Ga-DOTATATE PET-MRI)
Not yet recruiting
- Hypercholesterolemia
- +3 more
- Inclisiran
- +2 more
-
Cambridge, United KingdomUniversity of Cambridge
Jan 13, 2023
Acute Coronary Syndrome, STEMI Trial in Cairo (Colchicine Tablets)
Completed
- Acute Coronary Syndrome
- STEMI
- Colchicine Tablets
-
Cairo, EgyptAin shams university
Sep 22, 2023
Serum Soluble ST2 and Plaque Vulnerability in Acute Coronary
Completed
- Acute Coronary Syndrome
- Coronary plaque components
-
Shanghai, ChinaCardiology, Ren Ji Hospital
Mar 20, 2021
Iris Incarceration Trial in Minya (Subscleral Trabeculectomy (SST) with Iris incarceration, Conventional trabeculotomy)
Completed
- Iris Incarceration
- Subscleral Trabeculectomy (SST) with Iris incarceration
- Conventional trabeculotomy
-
Minya, EgyptMinia University
Oct 15, 2019
s of Galectin-3, Soluble ST2 and BNP in Predicting Clinical
Not yet recruiting
- ST Elevation Myocardial Infarction
- +2 more
- (no location specified)
Feb 17, 2022
Late Anthracycline Induced Cardiotoxicity- Childhood Cancer
Recruiting
- Anthracycline Induced Cardiotoxicity
-
Belfast, United KingdomBelfast Health and Social Care Trust
Sep 7, 2022
Adrenal Suppression Trial in Sheffield (nasal Tetracosactide, IV tetracosactide)
Suspended
- Adrenal Suppression
- nasal Tetracosactide
- IV tetracosactide
-
Sheffield, Sheffield (South Yorkshire District), United KingdomSheffield Children's NHS Foundation Trust
Jan 3, 2020
Cardiac Biomarkers and Analytical Methods
Active, not recruiting
- Cardiovascular Diseases
- Myocardial Injury
-
Roma, ItalySilvia Baroni
Mar 12, 2023
Patients With Septicemia
Completed
- Sepsis
- +2 more
-
Graz, Styria, AustriaMedical University Hospital of Graz
Aug 31, 2021
Skin and Soft Tissue (SST) Infection Trial in United States (Arm 1: Routine Care, Arm 2: INSPIRE CPOE Smart Prompt for Skin and
Not yet recruiting
- Skin and Soft Tissue (SST) Infection
- Arm 1: Routine Care
- Arm 2: INSPIRE CPOE Smart Prompt for Skin and Soft Tissue Infection
-
Riverside, California
- +101 more
Jun 14, 2022
Neuroendocrine Neoplasia's (NENs), Gastroenteropancreatic Neuroendocrine Tumour (GEP-NET) Trial in Basel (161Tb-DOTA-LM3,
Not yet recruiting
- Neuroendocrine Neoplasia's (NENs)
- Gastroenteropancreatic Neuroendocrine Tumour (GEP-NET)
-
Basel, SwitzerlandDivision of Nuclear Medicine, University Hospital Basel
Apr 27, 2022
Heart Failure, Heart Failure With Preserved Ejection Fraction Trial in Shenyang (Empagliflozin 10 Mg)
Enrolling by invitation
- Heart Failure
- Heart Failure With Preserved Ejection Fraction
- Empagliflozin 10 Mg
-
Shenyang, Liaoning, ChinaShengjing Hospital
Dec 22, 2022
Subjects With Coronary Syndrome (PLAQUE Study)
Recruiting
- Coronary Syndrome
- blood sample collection
-
Ancona, ItalyIRCCS INRCA Hospital
Oct 26, 2023